Benchmark’s vision is to be the leading provider of solutions in aquaculture genetics, health and specialist nutrition.
Our Investment Proposition
High growth markets
Focus on established, fast growing markets of genetics, health and specialist nutrition serving the increasingly important aquaculture sector.
Benchmark has a differentiated model bringing together genetics, health and specialist nutrition, which combined can contribute significantly to improve the sustainability and profitability of aquaculture producers.
Barriers to competition
Market leadership, strong patent portfolio, long established breeding programmes and accredited manufacturing capability.
Global distribution network and production capacity to support growth.
Potential to deliver high shareholder returns
High growth profile and target 25% EBITDA margin within 3 to five years.
Our Key Markets
Projected growth (2018-2020)1
Projected growth (2015-2019)2
Projected growth per annum2
1 GOAL (2017) Global Shrimp Production Review and Forecast.
2 Rabobank, 2017.
PDF, 590 KB
Three critical components in production cycle
Best starting point for production
- Salmon eggs
- Tilapia fingerlings
- Shrimp broodstock
- Genetic services for 10+ species
2018 Revenue £35.8m
First stage nutrition is key to growth and survivability
Early stage nutrition for shrimp and bass/bream
- Live feed (artemia)
- Larval diets
2018 Revenue £85.7m
Focused on the execution and launch of our rich pipeline of products
2018 Financial Headline
|Loss before tax||(13.7)||(8.1)|
|Basic loss per share (pence)||(0.94)||(1.4)|
Revenue split by divisions (FY18)
- Advanced Nutrition
- Knowledge Services